Form 8-K

8-K — VEECO INSTRUMENTS INC

Accession: 0001104659-26-055640

Filed: 2026-05-05

Period: 2026-05-05

CIK: 0000103145

SIC: 3559 (SPECIAL INDUSTRY MACHINERY, NEC)

Item: Results of Operations and Financial Condition

Item: Financial Statements and Exhibits

Documents

8-K — veco-20260505x8k.htm (Primary)

EX-99.1 (veco-20260505xex99d1.htm)

EX-99.2 (veco-20260505xex99d2.htm)

GRAPHIC (veco-20260505xex99d1001.jpg)

GRAPHIC (veco-20260505xex99d2g001.jpg)

GRAPHIC (veco-20260505xex99d2g002.jpg)

GRAPHIC (veco-20260505xex99d2g003.jpg)

GRAPHIC (veco-20260505xex99d2g004.jpg)

GRAPHIC (veco-20260505xex99d2g005.jpg)

GRAPHIC (veco-20260505xex99d2g006.jpg)

GRAPHIC (veco-20260505xex99d2g007.jpg)

GRAPHIC (veco-20260505xex99d2g008.jpg)

GRAPHIC (veco-20260505xex99d2g009.jpg)

GRAPHIC (veco-20260505xex99d2g010.jpg)

GRAPHIC (veco-20260505xex99d2g011.jpg)

GRAPHIC (veco-20260505xex99d2g012.jpg)

GRAPHIC (veco-20260505xex99d2g013.jpg)

GRAPHIC (veco-20260505xex99d2g014.jpg)

GRAPHIC (veco-20260505xex99d2g015.jpg)

GRAPHIC (veco-20260505xex99d2g016.jpg)

GRAPHIC (veco-20260505xex99d2g017.jpg)

GRAPHIC (veco-20260505xex99d2g018.jpg)

GRAPHIC (veco-20260505xex99d2g019.jpg)

GRAPHIC (veco-20260505xex99d2g020.jpg)

GRAPHIC (veco-20260505xex99d2g021.jpg)

GRAPHIC (veco-20260505xex99d2g022.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: veco-20260505x8k.htm · Sequence: 1

VEECO INSTRUMENTS INC._May 5, 2026

0000103145false00001031452026-05-052026-05-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 5, 2026

VEECO INSTRUMENTS INC.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction

of incorporation)

0-16244

(Commission

File Number)

11-2989601

(IRS Employer

Identification No.)

Terminal Drive, Plainview, New York 11803

(Address of principal executive offices)

(516) 677-0200

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

VECO

The NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On May 5, 2026, Veeco Instruments Inc. (“Veeco”) issued a press release announcing its financial results for the quarter ended March 31, 2026. In connection with the release and the related conference call, Veeco posted a presentation relating to its first quarter 2026 financial results on its website (www.veeco.com). Copies of the press release and presentation are furnished as Exhibit 99.1 and Exhibit 99.2 to this report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

EXHIBIT INDEX

Exhibit

Description

99.1

Press release issued by Veeco dated May 5, 2026

99.2

Veeco Q1 2026 Conference Call Presentation May 5, 2026

104

Cover Page Interactive Data File (formatted as inline XBRL).

Limitation on Incorporation by Reference

In accordance with general instruction B.2 of Form 8-K, the information in this report, including exhibits, is furnished pursuant to Items 2.02 and 9.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall this information or exhibits be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

May 5, 2026

VEECO INSTRUMENTS INC.

By:

/s/ Kirk Mackey

Name: Kirk Mackey

Title: Vice President, General Counsel

EX-99.1

Filename: veco-20260505xex99d1.htm · Sequence: 2

EXHIBIT 99.1

VEECO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

First Quarter 2026 Highlights:

● Revenue of $158.3 million, compared with $167.3 million in the same period last year

● GAAP net loss of $(0.3) million, or $(0.01) loss per diluted share, compared with net income of $11.9 million, or $0.20 earnings per diluted share in the same period last year

● Non-GAAP net income of $8.9 million, or $0.14 per diluted share, compared with $22.2 million, or $0.37 per diluted share in the same period last year

Plainview, N.Y., May 5, 2026 -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its first quarter ended March 31, 2026. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

U.S. Dollars in millions, except per share data

GAAP Results

Q1 '26

Q1 '25

Revenue

158.3

167.3

Net income (loss)

(0.3)

11.9

Diluted earnings (loss) per share

(0.01)

0.20

Non-GAAP Results

Q1 '26

Q1 '25

Operating income

8.6

24.3

Net income

8.9

22.2

Diluted earnings per share

0.14

0.37

“Veeco executed well in the first quarter as the industry enters a transformational period driven by rapid expansion of AI data centers and high-performance computing,” said Bill Miller, Ph.D., Veeco’s Chief Executive Officer. “This inflection is driving significant order activity across our portfolio, with particularly strong momentum in silicon photonics as customers scale optical connectivity and power-efficient technologies. Veeco’s differentiated process equipment is increasingly critical to this landscape, positioning us well for sustained, multi-year revenue growth.”

Guidance and Outlook

The following guidance is provided for Veeco’s second quarter 2026:

● Revenue is expected in the range of $170 million to $190 million

● GAAP diluted earnings per share are expected in the range of $0.02 to $0.15

● Non-GAAP diluted earnings per share are expected in the range of $0.20 to $0.32

The following guidance for Veeco’s fiscal year 2026 was previously provided and remains unchanged:

● Revenue is expected in the range of $740 million to $800 million

● GAAP diluted earnings per share are expected in the range of $0.83 to $1.17

● Non-GAAP diluted earnings per share are expected in the range of $1.50 to $1.85

Conference Call Information

A conference call reviewing these results has been scheduled for today, May 5, 2026 starting at 5:00pm ET. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

No Offer or Solicitation

This communication is not intended to and shall not constitute an offer to purchase or the solicitation of an offer to buy or sell any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, including trends related to artificial intelligence and high-performance computing, industry outlooks and demand drivers, statements regarding the pending merger with Axcelis, the timing of shipments, deliveries and revenue recognition, statements regarding shipments currently being held by U.S. Customs, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results, the timing, completion and expected benefits of the proposed transaction and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the effects of foreign and domestic tariffs and the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; cybersecurity attacks and our ability to safeguard sensitive information and protect our intellectual property rights in key technologies; the effects of regional or global health epidemics; delays in or failure to complete the proposed transaction, whether due to an inability by either party to satisfy one or more conditions to closing, including an inability to obtain regulatory approval in China, the occurrence of events or changes in circumstances that give rise to the termination of the applicable merger agreement by either party, or otherwise; risks related to the pendency of the proposed transaction and its effect on our business, financial condition, results of operations, cash flows and stock price; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees, including as a result of the proposed transaction; diversion of management time and attention from ordinary course business operations to the proposed transaction and other potential disruptions to our business relating thereto; the variability of

results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:

Investor Relations: Alex Delacroix (516) 528-1020adelacroix@veeco.com

Media: Brenden Wright (410) 984-2610bwright@veeco.com

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

Three months ended March 31,

2026

2025

Net sales

158,341

167,292

Cost of sales

102,513

98,825

Gross profit

55,828

68,467

Operating expenses, net:

Research and development

29,875

28,514

Selling, general, and administrative

26,016

25,028

Amortization of intangible assets

705

821

Merger costs

2,012

—

Other operating expense (income), net

(122)

(44)

Total operating expenses, net

58,486

54,319

Operating income (loss)

(2,658)

14,148

Interest income (expense), net

1,175

836

Income (loss) before income taxes

(1,483)

14,984

Income tax expense (benefit)

(1,159)

3,037

Net income (loss)

(324)

11,947

Income per common share:

Basic

(0.01)

0.21

Diluted

(0.01)

0.20

Weighted average number of shares:

Basic

60,414

57,753

Diluted

60,414

60,234

Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in thousands)

March 31,

December 31,

2026

2025

(unaudited)

Assets

Current assets:

Cash and cash equivalents

179,535

163,466

Short-term investments

203,796

226,763

Accounts receivable, net

150,521

110,685

Contract assets

21,723

34,838

Inventories

282,231

275,298

Prepaid expenses and other current assets

35,613

34,286

Total current assets

873,419

845,336

Property, plant and equipment, net

107,817

108,646

Operating lease right-of-use assets

24,084

24,606

Intangible assets, net

4,991

5,696

Goodwill

214,964

Deferred income taxes

124,141

122,935

Other assets

3,553

3,612

Total assets

1,352,969

1,325,795

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

60,153

55,345

Accrued expenses and other current liabilities

52,038

45,503

Contract liabilities

92,731

74,161

Income taxes payable

1,763

3,048

Total current liabilities

206,685

178,057

Deferred income taxes

513

532

Long-term debt

226,253

226,009

Long-term operating lease liabilities

31,140

31,837

Other liabilities

4,716

3,852

Total liabilities

469,307

440,287

Total stockholders’ equity

883,662

885,508

Total liabilities and stockholders’ equity

1,352,969

1,325,795

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with GAAP. These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Reconciliation of GAAP to Non-GAAP Financial Data (Q1 2026)

(in thousands)

(unaudited)

Non-GAAP Adjustments

Share-Based

Three months ended March 31, 2026

GAAP

Compensation

Amortization

Other

Non-GAAP

Net sales

158,341

Gross profit

55,828

1,511

57,339

Gross margin

35.3

36.2

Operating expenses

58,486

(7,000)

(705)

(2,012)

48,769

Operating income (loss)

(2,658)

8,511

705

2,012

8,570

Net income (loss)

(324)

8,511

705

(16)

8,876

- See table below for additional details.

Other Non-GAAP Adjustments (Q1 2026)

(in thousands)

(unaudited)

Three months ended March 31, 2026

Merger related expenses

2,012

Subtotal

2,012

Non-cash interest expense

244

Non-GAAP tax adjustment *

(2,272)

Total Other

(16)

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q1 2026)

(in thousands, except per share amounts)

(unaudited)

Three months ended March 31, 2026

GAAP

Non-GAAP

Numerator:

Net income (loss) available to common shareholders

(324)

8,876

Denominator:

Basic weighted average shares outstanding

60,414

Effect of potentially dilutive share-based awards

—

808

Dilutive effect of 2029 Convertible Senior Notes

—

642

Diluted weighted average shares outstanding

60,414

61,864

Net income (loss) per common share:

Basic

(0.01)

0.15

Diluted

(0.01)

0.14

Reconciliation of GAAP to Non-GAAP Financial Data (Q1 2025)

(in thousands)

(unaudited)

Non-GAAP Adjustments

Share-based

Three months ended March 31, 2025

GAAP

Compensation

Amortization

Other

Non-GAAP

Net sales

167,292

Gross profit

68,467

1,343

69,810

Gross margin

40.9

41.7

Operating expenses

54,319

(7,865)

(821)

(99)

45,534

Operating income

14,148

9,208

821

24,276

Net income

11,947

9,208

821

231

22,207

- See table below for additional details.

Other Non-GAAP Adjustments (Q1 2025)

(in thousands)

(unaudited)

Three months ended March 31, 2025

Other

Subtotal

Non-cash interest expense

257

Non-GAAP tax adjustment *

(125)

Total Other

231

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q1 2025)

(in thousands, except per share amounts)

(unaudited)

Three months ended March 31, 2025

GAAP

Non-GAAP

Numerator:

Net income

11,947

22,207

Interest expense associated with 2025 and 2027 Convertible Senior Notes

253

273

Net income available to common shareholders

12,200

22,480

Denominator:

Basic weighted average shares outstanding

57,753

Effect of potentially dilutive share-based awards

693

Dilutive effect of 2025 Convertible Senior Notes

—

174

Dilutive effect of 2027 Convertible Senior Notes (1)

1,788

1,354

Diluted weighted average shares outstanding

60,234

59,974

Net income per common share:

Basic

0.21

0.38

Diluted

0.20

0.37

(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q1 2026 and 2025)

(in thousands)

(unaudited)

Three months ended

March 31, 2026

March 31, 2025

GAAP Net income (loss)

(324)

11,947

Share-based compensation

8,511

9,208

Amortization

705

821

Merger related expenses

2,012

—

Interest (income) expense, net

(1,175)

(836)

Other

—

Income tax expense (benefit)

(1,159)

3,037

Non-GAAP Operating income

8,570

24,276

Reconciliation of GAAP to Non-GAAP Financial Data (Q2 2026)

(in millions, except per share amounts)

(unaudited)

Non-GAAP Adjustments

Guidance for the three months ending

Share-based

June 30, 2026

GAAP

Compensation

Amortization

Other

Non-GAAP

Net sales

170

190

170

190

Gross profit

—

Gross margin

37%

39%

38%

40%

Operating expenses

(7)

(1)

(2)

Operating income

Net income

Income per diluted common share

0.02

0.15

0.20

0.32

Income per Diluted Common Share (Q2 2026)

(in millions, except per share amounts)

(unaudited)

Guidance for the three months ending June 30, 2026

GAAP

Non-GAAP

Numerator:

Net income available to common shareholders

Denominator:

Basic weighted average shares outstanding

Effect of potentially dilutive share-based awards

Dilutive effect of 2029 Convertible Senior Notes

Diluted weighted average shares outstanding

Net income per common share:

Income per diluted common share

0.02

0.15

0.20

0.32

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q2 2026)

(in millions)

(unaudited)

Guidance for the three months ending June 30, 2026

GAAP Net income

Share-based compensation

Amortization

Merger related expense

Interest expense (income)

(1)

Income tax expense

Non-GAAP Operating income

Note: Amounts may not calculate precisely due to rounding.

Reconciliation of GAAP to Non-GAAP Financial Data (FY 2026)

(in millions, except per share amounts)

(unaudited)

Non-GAAP Adjustments

Guidance for the year ending

Share-based

December 31, 2026

GAAP

Compensation

Amortization

Other

Non-GAAP

Net sales

740

800

740

800

Gross profit

298

338

—

306

346

Gross margin

40%

42%

41%

43%

Operating expenses

244

259

(31)

(2)

(6)

205

220

Operating income

101

126

Net income

115

Income per diluted common share

0.83

1.17

1.50

1.85

Income per Diluted Common Share (FY 2026)

(in millions, except per share amounts)

(unaudited)

Guidance for the year ending December 31, 2026

GAAP

Non-GAAP

Numerator:

Net income available to common shareholders

115

Denominator:

Basic weighted average shares outstanding

Effect of potentially dilutive share-based awards

Dilutive effect of 2029 Convertible Senior Notes

Diluted weighted average shares outstanding

Net income per common share:

Income per diluted common share

0.83

1.17

1.50

1.85

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (FY 2026)

(in millions)

(unaudited)

Guidance for the year ending December 31, 2026

GAAP Net income

Share-based compensation

Amortization

Merger related expense

Interest expense (income)

(4)

Income tax expense

Non-GAAP Operating income

101

126

EX-99.2

Filename: veco-20260505xex99d2.htm · Sequence: 3

Exhibit 99.2

Q1 2026 Financial

Results Conference Call

May 5th, 2026

Veeco Instruments

Disclaimer

No Offer or Solicitation

solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made, except by means of a prospectus meeting the requirements of

Section 10 of the Securities Act of 1933, as amended.

Forward-looking Statements

This presentation contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s

expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify

forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, including trends

related to artificial intelligence and high-performance computing, statements regarding the pending merger with Axcelis, the timing of shipments, deliveries and revenue recognition, statements regarding shipments

currently being held by U.S. Customers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative

and the effects thereof on our operations and financial results, the timing, completion and expected benefits of the proposed transaction and other statements that are not historical facts. These statements and their

underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements

include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the effects of foreign and domestic tariffs and the ongoing trade disputes between the

U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products

and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; cybersecurity attacks and our ability to safeguard sensitive

information and protect our intellectual property rights in key technologies; the effects of regional or global health epidemics; delays in or failure to complete the proposed transaction, whether due to an inability by either

party to satisfy one or more conditions to closing, including an inability to obtain regulatory approval in China, the occurrence of events or changes in circumstances that give rise to the termination of the applicable merger

agreement by either party, or otherwise; risks related to the pendency of the proposed transaction and its effect on our business, financial condition, results of operations, cash flows and stock price; our ability to achieve

the objectives of operational and strategic initiatives and attract, motivate and retain key employees, including as a result of the proposed transaction; diversion of management time and attention from ordinary course

business operations to the proposed transaction and other potential disruptions to our business relating thereto; the variability of results among products and end-markets, and our ability to accurately forecast future

results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings

on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this

presentation. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this presentation.

Non-GAAP Financial Measures

This presentation also includes references to financial measures that are calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles in the United States

of America (“GAAP”). These non-GAAP measures include, but are not limited to, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income, non-GAAP net income and

non-GAAP diluted earnings per share. Any non-GAAP financial measures used in this presentation are in addition to, and should not be considered superior to, or a substitute for, financial statements prepared in accordance

with GAAP. Non-GAAP financial measures should not be considered in isolation or as an alternative to financial statements prepared in accordance with GAAP and are subject to significant inherent limitations. We believe

these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Veeco's financial condition and results of operations. The

non-GAAP measures presented herein should not be comparable to similar non-GAAP measures presented by other companies. These non-GAAP financial measures are subject to inherent limitations as they reflect the

exercise of judgments by management about which expense and income are excluded or included in determining these non-GAAP financial measures. A reconciliation of non-GAAP financial measures used in this

presentation to the most directly comparable GAAP financial measures is included in the Appendix.

Bill Miller, Ph.D.

CEO Overview

Q1 2026 Highlights

1. Major industry inflection with AI

infrastructure build-out

2. Order activity acceleration from back-half of 2025 into Q1 2026

3. Stronger than expected revenue

opportunity for InP laser manufacturing

4. Operational manufacturing footprint

expansion

5. Reiterate FY 2026 guide with increased

visibility into 2027

Revenue

$158M

Non-GAAP

Operating Income

$9M

Non-GAAP

EPS

0.14₵

Key Takeaways

Veeco’s Critical Role in Semi Manufacturing

Deposition Lithography Etch Ion Implant Anneal Inspection Adv.

Packaging

IBD

300

IBD

EUV

LSA NSA Wet

Processing Litho

New products

FRONT END BACK END

Driving business today

Representative Process Steps

Key:

IBD: Ion Beam Deposition

EUV: Extreme ultraviolet

LSA: Laser Spike Annealing

NSA: Nanosecond Annealing

System Tier 1 Customer Current Evaluations

LSA

Logic 1

Memory 1

NSA

Logic 2

Memory 0

IBD300

Logic 0

Memory 2

Note: Opportunity for forecasted revenue of $30M-$60M per application at 100K wspm

Semi SAM Expansion To Drive Outperformance

Key Process 2026 2030

Annealing

Laser Spike Annealing (LSA)

~$800M ~$1.3B

Nanosecond Annealing (NSA)

Ion Beam Deposition

IBD300 Front End Semi

~$120M ~$500M

IBD EUV Mask Blanks & Pellicles

Advanced Packaging Wet Processing and Lithography ~$600M ~$1.0B

Veeco’s Technology Enables Gate-All-Around, High-Bandwidth Memory, EUV Lithography and Advanced Packaging

Source: Veeco Served Available Market based on TrendFocus, Gartner, Yole Group and internal analysis

2026 2030

Total Served Available Market

Annealing IBD Advanced Packaging Services & Other

Projected

~12% CAGR

~$1.7B

~$3.0B

Veeco’s Critical Role in Compound Semi: Indium

Phosphide Laser Solutions

Repeat cycle depending on device

Epitaxy Patterning Metallization Anneal /

Cleave Etch Laser Facet

Coating

Lumina® MOCVD

InP Platform

Size of bubble represents approximate market opportunity

Veeco Provides Differentiated Solutions for Key Steps in manufacturing InP Lasers Driven by AI Infrastructure

Cumulative ~$2B Total Market Opportunity over the next several years

WaferEtch® /

WaferStorm®

Wet Processing Spector®

Ion Beam Deposition

Compound Semi Projected SAM Growth

Source: Veeco Served Available Market based on TrendFocus, Gartner, Yole Group and internal analysis

Key Driver 2026 2030

Silicon

Photonics

(InP Lasers)

• Lumina® MOCVD InP platform

• WaferEtch® and WaferStorm® systems

• Spector® IBD for laser diode facets coatings

~$300M ~$700M

Other

Photonics

• Lumina® MOCVD platform for red MicroLED and

solar cells

• Propel® 300 for GaN on Si MicroLED for AR / VR and

optical communications

~$300M ~$550M

GaN Power

• Propel® single wafer MOCVD platform for 200mm

and 300mm GaN

• Propel® 300mm GaN on Si evaluation system at

leading IDM customer

• Received Propel® 300mm pilot line order in 2H ‘25

~$150M ~$250M

Veeco’s Technology Supports AI, Power Efficiency, and Advanced Connectivity, which are Reshaping the Industry

2026 2030

Total Served Available Market

GaN Power InP Lasers Other Photonics

RF & Other Services

Projected

~15% CAGR

~$1.0B

~$2.0B

John Kiernan

CFO Overview

Revenue by Market Revenue by Region

Scientific &

Other

Semiconductor

Compound

Semiconductor

Data

Storage

ROW is negligible

13%

12%

69%

20%

13%

10%

57%

United States

EMEA

APAC

China

$158M

Revenue Trend ($M) Q1 25 Q4 25 Q1 26

Semiconductor 124 111 109

Compound Semi 14 20 19

Data Storage 7 10 10

Scientific & Other 22 24 20

Total 167 165 158

Revenue Trend ($M) Q1 25 Q4 25 Q1 26

APAC 60 90 90

USA 24 29 32

China 71 38 20

EMEA & ROW 12 8 16

Total 167 165 158

Q1 2026 Revenue by Market & Region

Amounts may not calculate precisely due to rounding.

Amounts may not calculate precisely due to rounding. A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation.

In millions

(except per share amounts)

GAAP Non-GAAP Non-GAAP

Q4 25 Q1 26 Q4 25 Q1 26

Q1 26 Guidance

(as of Feb. 25th, 2026)

Revenue $165.0 $158.3 $165.0 $158.3 $150M - $170M

Gross Profit 60.5 55.8 62.3 57.3

Gross Margin 36.7% 35.3% 37.7% 36.2% 37% - 38%

Operating Expenses 61.9 58.5 48.5 48.8 $48M - $50M

Operating Income (Loss) (1.4) (2.7) 13.8 8.6

Net Income (Loss) 1.1 (0.3) 14.7 8.9 $9M - $15M

Diluted Earnings Per Share (Loss) 0.02 (0.01) 0.24 0.14 $0.14 - $0.24

Diluted Shares 61.5 60.4 61.5 61.9

Q1 2026 Operating Results

Amounts may not calculate precisely due to rounding. A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation.

Balance Sheet and Cash Flow Highlights

$ millions Q4 2025 Q1 2026

Cash & Short-Term Investments 390 383

Accounts Receivable 111 151

Inventories 275 282

Accounts Payable 55 60

Long-Term Debt 226 226

Cash Flow from Operations 25 8

Capital Expenditures 3 5

DSO (days) 60 86

DIO (days) 232 245

DPO (days) 48 54

Q2 & FY 2026 Outlook

A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation.

Q2 2026 FY 2026

GAAP Non-GAAP GAAP Non-GAAP

Revenue $170M - $190M $170M - $190M $740M - $800M $740M - $800M

Gross Margin 37% - 39% 38% - 40% 40% - 42% 41% - 43%

Operating Expenses $62M - $65M $52M - $55M $244M - $259M $205M - $220M

Net Income $2M – $10M $12M - $21M $52M - $73M $94M - $115M

Diluted Earnings Per Share $0.02 – $0.15 $0.20 - $0.32 $0.83 - $1.17 $1.50 - $1.85

Q&A

Backup & Financial Tables

$M 2022 2023 2024 2025 2026

FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1

Semi 369.4 93.1 106.3 98.2 115.2 412.7 120.4 109.9 124.1 112.1 466.6 123.8 123.9 118.3 110.5 476.6 109.0

Compound

Semi 121.2 21.2 24.1 25.7 16.3 87.3 21.0 18.2 15.6 22.8 77.6 14.4 14.2 10.9 20.1 59.6 18.8

Data Storage 87.5 21.5 13.9 34.0 19.1 88.5 18.0 34.0 32.8 14.1 98.9 6.7 12.4 10.0 10.2 39.2 10.2

Scientific &

Other 68.0 17.7 17.4 19.6 23.4 78.0 15.1 13.8 12.4 33.0 74.2 22.4 15.7 26.7 24.2 88.9 20.3

Total 646.1 153.5 161.6 177.4 173.9 666.4 174.5 175.9 184.8 182.1 717.3 167.3 166.1 165.9 165.0 664.3 158.3

Historical Revenue by End-Market

Amounts may not calculate precisely due to rounding.

2029 Convertible Notes Outstanding

Convertible

Notes Due

June 2029

Principal

Amount

Carrying

Value Coupon

Annual

Cash

Interest

Annual

Non-Cash

Interest

Initial

Conversion

Price

230M 226M 2.875% 6.6M 1.1M 29.22

As of March 31, 2026

* The Company is required to settle the principal amount of the 2029 Convertible Notes in cash,and has the option to settle the excess above principal in any combination of

cash or shares. As such, only “in-the-money” shares above the implied conversion price of $29.22 are added to the diluted share count, and there is no interest expense add-back to the numerator for purposes of calculating diluted EPS.

Effect of Convertible Notes on Diluted EPS

(GAAP and Non-GAAP)*

Average Stock Price per

Common Share

Incremental Dilutive

Shares (in thousands)

$29.00 -

$30.00 205

$35.00 1,300

$40.00 2,121

$45.00 2,760

$50.00 3,271

$55.00 3,689

$60.00 4,037

Note on Reconciliation Tables

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore

not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial

measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction

costs, non-cash amortization of acquired intangible assets, incremental transaction-related compensation, and certain

integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies.

Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial

performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended

to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made

by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income,

which is used to determine management incentive compensation as well as to forecast future periods.

These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental

information used by management in its financial and operational decision-making. In addition, similar Non-GAAP

financial measures have historically been reported to investors; the inclusion of comparable numbers provides

consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial

measures used in this news release to their most directly comparable GAAP financial measures.

Supplemental Information—GAAP to Non-GAAP Reconciliation

$ millions Q4 25 Q1 26

Net sales $165.0 $158.3

GAAP gross profit 60.5 55.8

GAAP gross margin 36.7% 35.3%

Add: Share-based comp 1.7 1.5

Non-GAAP gross profit $62.3 $57.3

Non-GAAP gross margin 37.7% 36.2%

$ millions Q4 25 Q1 26

GAAP Net income (loss) $1.1 ($0.3)

Add: Share-based comp 9.0 8.5

Add: Amortization 0.7 0.7

Add: Merger related expenses 6.3 2.0

Add: Changes in contingent consideration (0.9) -

Add: Interest expense (income) (1.3) (1.2)

Add: Tax expense (benefit) (1.2) (1.2)

Non-GAAP operating income $13.8 $8.6

$ millions, except per share amounts Q4 25 Q1 26

GAAP Basic weighted average shares 60.1 60.4

GAAP Diluted weighted average shares 61.5 60.4

GAAP Basic EPS $0.02 ($0.01)

GAAP Diluted EPS $0.02 ($0.01)

GAAP Net income (loss) $1.1 ($0.3)

Add: Share-based comp 9.0 8.5

Add: Amortization 0.7 0.7

Add: Merger related expenses 6.3 2.0

Add: Changes in contingent consideration (0.9) -

Add: Non-cash interest expense 0.3 0.2

Add: Tax adjustment from GAAP to Non-GAAP (1.8) (2.3)

Non-GAAP net income 14.7 8.9

Non-GAAP basic EPS $0.24 $0.15

Non-GAAP diluted EPS $0.24 $0.14

Non-GAAP basic weighted average shares 60.1 60.4

Non-GAAP diluted weighted average shares 61.5 61.9

$ millions Q4 25 Q1 26

GAAP operating expenses $61.9 $58.5

Share-based compensation (7.3) (7.0)

Amortization (0.7) (0.7)

Merger related expenses (6.3) (2.0)

Changes in contingent consideration and other 0.9 -

Non-GAAP operating expenses $48.5 $48.8

Amounts may not calculate precisely due to rounding.

$ millions Non-GAAP Adjustments

GAAP

Share-Based

Compensation Amortization Other Non-GAAP

Net Sales $158.3 $158.3

Gross Profit 55.8 1.5 — — 57.3

Gross Margin 35.3% 36.2%

Operating Expenses $58.5 (7.0) (0.7) (2.0) $48.8

Operating Income (Loss) ($2.7) 8.5 0.7 2.0 $8.6

Net Income (Loss) ($0.3) 8.5 0.7 0.0 $8.9

Q1 2026 Actual: GAAP to Non-GAAP Reconciliation

Income per Diluted Common Share

GAAP Non-GAAP

Net Income (Loss) available to common shareholders ($0.3) $8.9

Basic weighted average common shares 60.4 60.4

Add: Dilutive effect of share-based awards — 0.8

Add: Dilutive effect of 2029 Convertible Senior Notes — 0.6

Diluted weighted average common shares 60.4 61.9

Basic income (loss) per common share ($0.01) $0.15

Diluted income (loss) per common share ($0.01) $0.14

Other Non-GAAP Adjustments

Merger related expenses 2.0

Subtotal 2.0

Non-cash Interest Expense 0.2

Non-GAAP tax adjustment (2.3)

Total Other $0.0

Amounts may not calculate precisely due to rounding.

Reconciliation of GAAP to non-GAAP Financial Data

Non-GAAP Adjustments

GAAP

Share-Based

Compensation Amortization Other Non-GAAP

Net Sales $170–$190 $170–$190

Gross Profit 63–74 2 — — 65–76

Gross Margin 37%–39% 38%–40%

Operating Expenses $62–$65 (7) (1) (2) $52–$55

Operating Income $1–$10 9 1 2 $13–$22

Net Income $2–$10 9 1 1 $12–$21

Income per Diluted Share $0.02–$0.15 $0.20–$0.32

Q2 2026 Guidance

($ millions, except per share amounts)

Reconciliation of GAAP Net Income to non-GAAP Operating Income

GAAP Net Income $2–$10

Share-Based Compensation 9

Amortization 1

Merger related expenses 2

Interest expense (income) (1)

Income tax expense (benefit) 1

Non-GAAP Operating Income $13–$22

Amounts may not calculate precisely due to rounding.

Income per Diluted Common Share

GAAP Non-GAAP

Net income available to common shareholders $2–$10 $12–$21

Basic weighted average common shares 61 61

Add: Dilutive effect of share-based awards 1 1

Add: Dilutive effect of 2029 Convertible Senior Notes 2 2

Diluted weighted average common shares 64 64

Income per diluted common share $0.02-$0.15 $0.20-$0.32

Reconciliation of GAAP to non-GAAP Financial Data

Non-GAAP Adjustments

GAAP

Share-Based

Compensation Amortization Other Non-GAAP

Net Sales $740–$800 $740–$800

Gross Profit 298–338 8 — — 306–346

Gross Margin 40%–42% 41%–43%

Operating Expenses $244–$259 (31) (2) (6) $205–$220

Operating Income $54–$79 39 2 6 $101–$126

Net Income $52–$73 39 2 1 $94–$115

Income per Diluted Share $0.83–$1.17 $1.50–$1.85

FY 2026 Guidance

($ millions, except per share amounts)

Reconciliation of GAAP Net Income to non-GAAP Operating Income

GAAP Net Income $52–$73

Share-Based Compensation 39

Amortization 2

Merger related expenses 6

Interest expense (income) (4)

Income tax expense (benefit) 7-10

Non-GAAP Operating Income $101–$126

Amounts may not calculate precisely due to rounding.

Income per Diluted Common Share

GAAP Non-GAAP

Net income available to common shareholders $52–$73 $94–$115

Basic weighted average common shares 61 61

Add: Dilutive effect of share-based awards 1 1

Add: Dilutive effect of 2029 Convertible Senior Notes 1 1

Diluted weighted average common shares 63 63

Income per diluted common share $0.83-$1.17 $1.50-$1.85

GRAPHIC

Filename: veco-20260505xex99d1001.jpg · Sequence: 4

Binary file (8276 bytes)

Download veco-20260505xex99d1001.jpg

GRAPHIC

Filename: veco-20260505xex99d2g001.jpg · Sequence: 5

Binary file (80325 bytes)

Download veco-20260505xex99d2g001.jpg

GRAPHIC

Filename: veco-20260505xex99d2g002.jpg · Sequence: 6

Binary file (399046 bytes)

Download veco-20260505xex99d2g002.jpg

GRAPHIC

Filename: veco-20260505xex99d2g003.jpg · Sequence: 7

Binary file (37805 bytes)

Download veco-20260505xex99d2g003.jpg

GRAPHIC

Filename: veco-20260505xex99d2g004.jpg · Sequence: 8

Binary file (116208 bytes)

Download veco-20260505xex99d2g004.jpg

GRAPHIC

Filename: veco-20260505xex99d2g005.jpg · Sequence: 9

Binary file (140438 bytes)

Download veco-20260505xex99d2g005.jpg

GRAPHIC

Filename: veco-20260505xex99d2g006.jpg · Sequence: 10

Binary file (130793 bytes)

Download veco-20260505xex99d2g006.jpg

GRAPHIC

Filename: veco-20260505xex99d2g007.jpg · Sequence: 11

Binary file (139251 bytes)

Download veco-20260505xex99d2g007.jpg

GRAPHIC

Filename: veco-20260505xex99d2g008.jpg · Sequence: 12

Binary file (142502 bytes)

Download veco-20260505xex99d2g008.jpg

GRAPHIC

Filename: veco-20260505xex99d2g009.jpg · Sequence: 13

Binary file (36751 bytes)

Download veco-20260505xex99d2g009.jpg

GRAPHIC

Filename: veco-20260505xex99d2g010.jpg · Sequence: 14

Binary file (122463 bytes)

Download veco-20260505xex99d2g010.jpg

GRAPHIC

Filename: veco-20260505xex99d2g011.jpg · Sequence: 15

Binary file (123341 bytes)

Download veco-20260505xex99d2g011.jpg

GRAPHIC

Filename: veco-20260505xex99d2g012.jpg · Sequence: 16

Binary file (104366 bytes)

Download veco-20260505xex99d2g012.jpg

GRAPHIC

Filename: veco-20260505xex99d2g013.jpg · Sequence: 17

Binary file (134806 bytes)

Download veco-20260505xex99d2g013.jpg

GRAPHIC

Filename: veco-20260505xex99d2g014.jpg · Sequence: 18

Binary file (23084 bytes)

Download veco-20260505xex99d2g014.jpg

GRAPHIC

Filename: veco-20260505xex99d2g015.jpg · Sequence: 19

Binary file (43526 bytes)

Download veco-20260505xex99d2g015.jpg

GRAPHIC

Filename: veco-20260505xex99d2g016.jpg · Sequence: 20

Binary file (115667 bytes)

Download veco-20260505xex99d2g016.jpg

GRAPHIC

Filename: veco-20260505xex99d2g017.jpg · Sequence: 21

Binary file (108061 bytes)

Download veco-20260505xex99d2g017.jpg

GRAPHIC

Filename: veco-20260505xex99d2g018.jpg · Sequence: 22

Binary file (297397 bytes)

Download veco-20260505xex99d2g018.jpg

GRAPHIC

Filename: veco-20260505xex99d2g019.jpg · Sequence: 23

Binary file (127378 bytes)

Download veco-20260505xex99d2g019.jpg

GRAPHIC

Filename: veco-20260505xex99d2g020.jpg · Sequence: 24

Binary file (139621 bytes)

Download veco-20260505xex99d2g020.jpg

GRAPHIC

Filename: veco-20260505xex99d2g021.jpg · Sequence: 25

Binary file (129628 bytes)

Download veco-20260505xex99d2g021.jpg

GRAPHIC

Filename: veco-20260505xex99d2g022.jpg · Sequence: 26

Binary file (131459 bytes)

Download veco-20260505xex99d2g022.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 31

v3.26.1

Document and Entity Information

May 05, 2026

Cover [Abstract]

Document Type

8-K

Document Period End Date

May 05, 2026

Entity Registrant Name

VEECO INSTRUMENTS INC.

Entity Incorporation, State or Country Code

Entity File Number

0-16244

Entity Tax Identification Number

11-2989601

Entity Address, Address Line One

Terminal Drive

Entity Address, City or Town

Plainview

Entity Address, State or Province

Entity Address, Postal Zip Code

11803

City Area Code

516

Local Phone Number

677-0200

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.01 per share

Trading Symbol

VECO

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

Entity Central Index Key

0000103145

Amendment Flag

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration